华邦健康：多板块协同发力 预计2025年归母净利润6.6亿—7.3亿元

Core Viewpoint - Huabang Health (002004) is expected to achieve a net profit attributable to shareholders of 660 million to 730 million yuan in 2025, marking a turnaround from a loss in the previous year [1] Financial Performance - The company anticipates basic earnings per share of 0.33 to 0.37 yuan, compared to a loss of 0.15 yuan per share in the same period last year [1] Strategic Focus - The company is committed to its core business and is executing a strategic approach characterized by "cautious expansion, reduced financing, deep market penetration, and strong barriers," aimed at enhancing core competitiveness [1] Business Segments - The agricultural chemical new materials segment is experiencing a partial industry recovery, with the company actively exploring markets and improving management efficiency to enhance overall performance [1] - The pharmaceutical and tourism segments are also showing steady growth, contributing to the overall improvement in the company's performance [1]